Statistics on Biotechnology Use Results by fields of operation Total sectors. Biotechnology results by main variables and fields of operation. Unidades: Total 2019 Companies P.A. Higher Education PNPI Companies that perform R+D in Biotechnology 1.399 1.198 122 66 13 %Companies according to biotechnology used: Genetic code 40,8 33,3 88,5 87,9 38,5 %Companies according to biotechnology used: Functional Companies 46,7 39,8 88,5 92,4 53,8 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 31,5 24,2 73 83,3 53,8 %Companies according to biotechnology used: Bioprocesses 52,4 49,6 59 92,4 46,2 %Companies according to biotechnology used: Sub-cellular organisms 14,4 6,7 56,6 72,7 38,5 %Companies according to biotechnology used: Bio-computing 30,8 23,9 71,3 84,8 15,4 %Companies according to biotechnology used: Nanobiotechnology 17,4 11,2 50,8 71,2 7,7 %Companies according to biotechnology used: Other 13,9 14,6 7,4 15,2 7,7 Companies in which biotechnology activities are: Main and/or exclusive 685 644 33 2 6 Companies in which biotechnology activities are: A secondary line of business 253 171 37 43 2 Companies in which biotechnology activities are: A tool necessary for production 461 383 52 21 5 %Companies by field(s) of ultimate application of biotechnology use: Human health 52 47 77 91 62 %Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 21 19 16 68 8 %Companies by field(s) of ultimate application of biotechnology use: Food products 33 33 19 80 8 %Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production: 26 24 20 71 23 %Companies by field(s) of ultimate application of biotechnology use: Environment 18 15 21 74 15 %Companies by field(s) of ultimate application of biotechnology use: Industry 16 13 13 70 8 Personnel in R&D in biotechnology (no. of persons) 43.523 13.615 14.682 15.063 163 Personnel in R&D in biotechnology (no. of persons): Researchers 28.702 7.436 9.191 11.968 107 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 14.820 6.178 5.491 3.095 56 Personnel in R&D in biotechnology (no. of persons): women 24.516 7.639 9.277 7.494 106 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 15.356 4.095 5.444 5.753 64 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 9.160 3.544 3.833 1.741 42 Personnel in R&D in biotechnology (FTE) 29.655,1 9.365,2 11.013,2 9.177,3 99,4 Personnel in R&D in biotechnology (FTE): Researchers 19.150,3 5.410,6 6.546,6 7.128,5 64,6 Personnel in R&D in biotechnology (FTE): Technicians and assistants 10.504,8 3.954,6 4.466,6 2.048,8 34,8 Personnel in R&D in biotechnology (FTE): women 16.997,1 5.385,8 6.959,9 4.581,4 70 Personnel in R&D in biotechnology (FTE): (women) Researchers 10.349,2 3.032,9 3.876,1 3.397,2 43 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 6.647,9 2.352,9 3.083,8 1.184,2 27 Internal expenditure on R&D (thousands of euros) 2.040.323 940.230 652.393 442.089 5.611 1) By nature of the expense: Current expenses 1.899.869 871.813 608.579 413.960 5.517 1.1) Remuneration to researchers 776.880 284.936 242.168 247.973 1.802 1.2) Remuneration to technicians and assistants 333.017 148.254 118.062 65.769 931 1.3) Other current expenses 789.972 438.623 248.348 100.217 2.784 2) By nature of the expense: Capital expenses 140.454 68.417 43.814 28.129 94 2.1) Land and buildings 30.677 11.763 11.874 7.040 0 2.2) Equipment and instruments 90.306 39.641 31.009 19.567 89 2.3) Acquisition of specific R+D software 4.900 2.831 757 1.310 3 2.4) Otros productos de propiedad intelectual específicos para I+D 14.571 14.183 173 212 2 1.1) By origin of the funds: Own funds 742.583 577.287 78.505 86.280 511 1.2) By origin of the funds: From companies 268.227 142.672 96.507 28.164 884 1.3) By origin of the funds: Public Administration funds 783.942 102.630 396.610 282.374 2.327 1.4) By origin of the funds: From Universities 2.785 457 1.190 1.138 0 1.5) By origin of the funds: From non profit private institutions 30.232 9.631 13.309 5.740 1.553 1.6) By origin of the funds: Foreign funds 212.555 107.553 66.273 38.392 336 Purchase of services R & D in Biotechnology to (thousands of euros) 133.151 114.839 12.728 5.216 368 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain 85.933 69.258 11.630 4.727 318 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad 47.219 45.581 1.098 489 51 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 44,2 41,8 57,4 56,1 76,9 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 11,3 12 2,5 12,1 23,1 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 16,8 13,1 39,3 40,9 30,8 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 13,4 10,7 28,7 33,3 23,1 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 18,1 15,1 32,8 42,4 30,8 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels 18 16 30 41 23 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 15,2 15,9 9 10,6 38,5 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 37 37 41 36 39 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 51,9 50,7 57,4 63,6 53,8 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 19,1 19 20,5 16,7 30,8 %Companies that have requested biotechnology patents in Biotechnology 23,7 18,3 53,3 69,7 7,7 Number of patents requested 1.846 643 667 535 1 Notas: '..'=data not available '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent (*) Total calculated from the total number of companies with related activities with Biotechnology and the total Companies from other sectors with activities in R&D in Biotechnology Fuente: National Statistics Institute